Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-03 Sale |
2025-03-04 5:05 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,409 | $1.83 | $84,928 | 2,877,777 (Indirect Direct) |
View |
2025-02-03 Sale |
2025-02-04 5:54 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
144,250 | $2.1 | $302,925 | 4,326,086 (Indirect Direct) |
View |
2024-02-29 Sale |
2024-03-01 5:47 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,570 | $1.58 | $73,581 | 2,364,436 (Indirect Direct) |
View |
2024-02-27 Sale |
2024-02-29 6:00 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
37,733 | $1.52 | $57,354 | 2,411,006 (Indirect Direct) |
View |
2024-02-01 Sale |
2024-02-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
46,489 | $1.68 | $78,102 | 3,353,939 (Indirect Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:28 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
115 | $0.3481 | $40 | 152,501 (Direct) |
View |
2023-03-01 Sale |
2023-03-03 08:01 am |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
91,868 | $0.8775 | $80,614 | 1,888,728 (Indirect Direct) |
View |
2023-02-27 Sale |
2023-03-01 4:07 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
38,632 | $0.8132 | $31,416 | 1,980,596 (Indirect Direct) |
View |
2022-06-14 Sale |
2022-06-16 9:48 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
53 | $1.01 | $54 | 67,719 (Direct) |
View |
2022-02-28 Sale |
2022-03-02 9:25 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
79,026 | $2.1657 | $171,143 | 2,462,803 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-01 8:32 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
4,109 | $3.4 | $13,971 | 1,534,103 (Indirect Direct) |
View |
2021-03-01 Sale |
2021-03-02 4:10 pm |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
49,990 | $3.3961 | $169,771 | 1,902,292 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-31 Option Award |
2025-02-04 5:54 pm |
N/A 2027-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
2,102,900 | $0 | 4,326,086 (Direct) |
View |
2024-01-31 Option Award |
2024-02-02 4:10 pm |
N/A 2034-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,508,700 | $0 | 3,353,939 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 09:58 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
80,765 | $0 | 0 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:28 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
119,560 | $0 | 152,501 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 4:15 pm |
N/A 2033-01-31 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,803,438 | $0 | 3,529,541 (Direct) |
View |
2022-06-14 Option Award |
2022-06-16 9:48 pm |
N/A 2032-06-14 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
57,772 | $0 | 67,719 (Direct) |
View |
2022-02-28 Option Award |
2022-03-02 9:25 pm |
N/A 2032-02-28 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
1,032,825 | $0 | 2,462,803 (Direct) |
View |
2021-08-03 Option Award |
2021-08-05 5:28 pm |
N/A 2031-08-03 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
12,500 | $0 | 17,500 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 7:17 pm |
N/A N/A |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
39,520 | $0 | 1,538,212 (Direct) |
View |
2021-02-26 Option Award |
2021-03-02 4:10 pm |
N/A 2031-02-26 |
Akebia Therapeutics Inc. | AKBA | Butler John P. CEO and President |
641,000 | $0 | 1,902,292 (Direct) |
View |
2020-06-10 Option Award |
2020-06-11 5:40 pm |
N/A 2030-06-10 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |